Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA214611
Max Phase: Preclinical
Molecular Formula: C10H9NO4S
Molecular Weight: 239.25
Molecule Type: Small molecule
Associated Items:
ID: ALA214611
Max Phase: Preclinical
Molecular Formula: C10H9NO4S
Molecular Weight: 239.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)[C@H]1CSC(c2cc(O)ccc2O)=N1
Standard InChI: InChI=1S/C10H9NO4S/c12-5-1-2-8(13)6(3-5)9-11-7(4-16-9)10(14)15/h1-3,7,12-13H,4H2,(H,14,15)/t7-/m1/s1
Standard InChI Key: UZKPUFNAUXBOOI-SSDOTTSWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 239.25 | Molecular Weight (Monoisotopic): 239.0252 | AlogP: 1.04 | #Rotatable Bonds: 2 |
Polar Surface Area: 90.12 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.09 | CX Basic pKa: 0.53 | CX LogP: 2.07 | CX LogD: -1.40 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.67 | Np Likeness Score: 1.22 |
1. Bergeron RJ, Wiegand J, McManis JS, Bharti N.. (2006) The design, synthesis, and evaluation of organ-specific iron chelators., 49 (24): [PMID:17125256] [10.1021/jm0608816] |
Source(1):